Voices Against Brain Cancer Responds to Research Identifying New Way Doctors Can Detect Whether Breast Cancer Will Spread to Brain
Voices Against Brain Cancer (VABC) responds to an article posted by Cancer Research UK detailing key cancer research
New York, NY (PRWEB) April 26, 2013
On April 26, Voices Against Brain Cancer (VABC) responds to an article posted by Cancer Research UK detailing how researchers may have discovered a new tactic that will help predict whether or not cases of breast cancer will spread to the brain.
The Cancer Research UK article states that a team of researchers based at Baylor College of Medicine in Texas took breast cancer cells that had broken away from tumors and entered women´s bloodstreams. They then grew these cells in a laboratory. After analyzing these cells, researchers discovered that those cells from women whose cancer had spread to the brain “bore a unique combination of proteins in their surface.”
These particular cells, called circulating tumor cells (CTCs), travel through the bloodstream. If they are able to cross the blood-brain barrier, which is the brain´s natural defense mechanism, they can form brain tumors.
Michael Klipper, chairman for Voices Against Brain Cancer, responds to the findings. “This recent finding is a huge step forward for brain cancer research. If we are able to identify which cells cause the spreading of cancer to the brain, we can find new ways to treat the disease and make it more preventable.”
VABC has a wide variety of initiatives in place for brain cancer research, awareness and support. The organization´s research grants fund cutting-edge research programs that will have a monumental impact on the diagnosis and treatment of brain cancer. VABC currently funds research at several esteemed institutions such as Brookhaven National Laboratory, Cleveland Clinic, Columbia, Cornell, Duke, Harvard, John Hopkins, Memorial Sloan-Kettering and Yale, to name a few.
VABC’s mission is to find a cure for brain cancer by advancing scientific research, increasing awareness within the medical community and supporting patients, their families and caregivers afflicted with this devastating disease.
For press inquiries, please contact 5W Public Relations at 5wpr.com.
For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2013/4/prweb10661473.htm